Exhibit 99.29
Village Farms International, Inc.
Management’s Discussion and Analysis
Three and Six Months Ended June 30, 2017
August 14, 2017
Management’s Discussion and Analysis
Information is presented in thousands of United States dollars (“U.S. dollars”) unless otherwise noted.
Introduction
This management’s discussion and analysis (“MD&A”) should be read in conjunction with the condensed consolidated interim financial statements and accompanying notes of Village Farms International, Inc. (“VFF” and, together with its subsidiaries, the “Company”), for the six months ended June 30, 2017 (“the Consolidated Financial Statements”). The information provided in this MD&A is current to August 14, 2017 unless otherwise noted.
VFF is a corporation existing under the Canada Business Corporations Act. The Company’s principal operating subsidiaries at June 30, 2017 were Village Farms Canada Limited Partnership (“VFCLP”), Village Farms, L.P. (“VFLP”) and VF Clean Energy, Inc. (“VFCE”). VFF also owns a 50% equity interest in Pure Sunfarms Corp.
Basis of Presentation
The interim data included in the MD&A is presented in accordance with International Financial Reporting Standards (“IFRS”) as issued by the International Accounting Standards Board (“IASB”), unless otherwise noted.
The preparation of interim financial data requires the use of certain accounting estimates. It also requires management to exercise its judgment in the process of applying the Company’s accounting policies. The areas involving a higher degree of judgment or complexity, or areas where assumptions and estimates are significant to the interim financial data are disclosed in note 2 of the condensed consolidated interim financial statements of the Company.
Segment Reporting
Operating segments are reported in a manner consistent with the internal reporting provided to the chief operating decision-maker. The chief operating decision-maker, who is responsible for allocating resources and assessing performance of the operating segments, has been identified as the CEO. Based on the aggregation criteria in IFRS 8, Operating Segments, the operating segments of the Company are treated as two reporting segments.
Functional and Presentation Currency
The financial data is presented in U.S. dollars, which is the Company’s functional currency. All financial information presented in U.S. dollars has been rounded to the nearest thousand.
Business Overview
Management believes that the Company is one of the largest producers, marketers and distributors of premium-quality, greenhouse-grown tomatoes, bell peppers and cucumbers in North America. These premium products are grown in sophisticated, highly intensive agricultural greenhouse facilities located in British Columbia and Texas. The Company also markets and distributes premium tomatoes, peppers and cucumbers produced under exclusive arrangements with other greenhouse producers. The Company primarily markets and distributes under its Village Farms® brand name, primarily to retail supermarkets and dedicated fresh food distribution companies throughout the United States and Canada. It currently operates two distribution centres, one located in the United States and one in Canada. Since its inception, the Company has been guided by a sustainable agriculture policy which integrates four main goals – environmental health, economic profitability and social and economic equality. The Company, through its subsidiary VFCE, owns and operates a 7.0 MW power plant from landfill gas that generates electricity and provides thermal heat, in colder months, to one of the Company’s adjacent British Columbia greenhouse facilities and sells electricity to British Columbia Hydro and Power Authority (“BC Hydro”).
2
The Company embraces sustainable agriculture and environmentally-friendly growing practices by:
| • | utilizing integrated pest management techniques that use “beneficial bugs” to control unwanted pests. The use of natural biological control technology keeps plants and their products virtually free of chemical agents. The process includes regular monitoring techniques for threat identification, development of appropriate, tailored response strategies and the execution of these strategies; |
| • | capturing rainwater from various greenhouse roofs for irrigation purposes; |
| • | capturing landfill gas on a long term contract from the City of Vancouver landfill to generate electricity under a long term contract with BC Hydro and thermal heat for an adjacent greenhouse; |
| • | recycling water and nutrients during the production process; |
| • | growing plants in a natural medium, including coconut fibre and rock wool, as opposed to growing in the soil and depleting nutrients; and |
| • | using dedicated environmental control computer systems which monitor and control virtually all aspects of the growing environment, thereby maximizing the efficient use of energy. |
The Company’s assets include seven greenhouses providing approximately 950,085 square metres (or approximately 240 acres) of growing space in Canada and the United States. All of the Company’s greenhouses are constructed of glass, aluminum and steel, and are located on land owned or leased by the Company. The Company also has marketing agreements with growers in Canada, United States and Mexico that currently operate approximately 550,000 square metres (or approximately 138 acres) of growing area.
The following table outlines the Company’s greenhouse facilities:
| Growing Area |
| |||||||||
| Greenhouse Facility | Square Metres | Acres | Products Grown | |||||||
Marfa, TX (2 greenhouses) | 234,795 | 60 | Tomatoes on-the-vine, beefsteak tomatoes, specialty tomatoes | |||||||
Fort Davis, TX (1 greenhouse) | 156,530 | 40 | Specialty tomatoes | |||||||
Monahans, TX (1 greenhouse) (Permian Basin facility) | 118,200 | 30 | Tomatoes on-the-vine, long English cucumbers | |||||||
Delta, BC (3 greenhouses) | 440,560 | 110 | Tomatoes on-the-vine, beefsteak tomatoes, specialty tomatoes | |||||||
|
|
|
| |||||||
Total | 950,085 | 240 | ||||||||
Marketing
The Company is a leading marketer of premium-quality, value-added, branded greenhouse-grown produce in North America, and is a significant producer of tomatoes on-the-vine, beefsteak, cocktail, grape, cherry tomatoes, roma, Mini San Marzano (a tomato variety for which the Company currently has an exclusive agreement with the seed provider to be the sole grower in North America), other speciality tomatoes under exclusive agreements and long English cucumbers at its facilities. The Company also distributes and markets premium tomatoes, bell peppers and cucumbers in the United States and Canada produced by other greenhouse growers located in Canada and Mexico. The Company maintains high standards of food safety and requires the same of its contract growers, while providing on-time, effective and efficient distribution.
The Company strives to continually exceed the expectations of its customers by consistently providing superior product, including adding new product varieties and packaging innovations.
The Company has distribution capabilities that it believes exceed those of most of its competitors in the North American greenhouse vegetable industry. With leased distribution centres in Texas and British Columbia, the Company provides its customers with flexibility in purchasing. For the six months ended June 30, 2017, the Company had an on-time delivery record of approximately 98.0%, while maintaining competitive freight rates that management of the Company believes to be among the best in the industry.
The Company’s marketing strategy is to strategically position the Company to be the supplier of choice for retailers offering greenhouse produce by focusing on the following:
| • | Year-Round Supplier. Year-round production capability of the Company enhances customer relationships, resulting in more consistent pricing. |
3
| • | Quality and Food Safety. Sales are made directly to retailers which ensure control of the product from seed to customer and results in higher levels of food safety, shelf life and quality control. Food safety is an integral part of the Company’s operations, and management believes that it has led, and currently leads, the industry in adopting Good Agricultural Practices. This program is modeled after the U.S. Food and Drug Administration’s Good Manufacturing Practices using the Primus Labs® format and third party auditors. All of the Company’s packing facilities undergo comprehensive food safety audits by Primus Labs®. |
| • | Quality Packaging and Presentation. Product is selected at a uniform size and picked at the same stage of vine ripeness. The packaging for the product is “display ready”, ensuring retail customers have a full view of the product on the supermarket shelf. |
| • | Exclusive Varieties. The Company expands its product profile, to create and drive exclusive varietal relationships in North America that enable the Company to present consumers with an enhanced eating experience with the Village Farms brand. |
| • | Direct Sale to Retail Customers. Greenhouse produce (produce grown by the Company plus supply partner produce) is sold directly to supermarket chains, including, Associated Grocers, Associated Wholesale Grocers, BJ’s Wholesale Club Inc., Costco Wholesale, Fairway bakery LLC, Fred Meyer, Fresh Thyme Farmers Markets, The Fresh Market, Inc., Giant Eagle, Harris Teeter Supermarkets, Inc., HEB Grocery Company, The Kroger Co., Loblaw Companies Limited, Publix Super Markets, Inc., Roundy’s Supermarkets, Inc., Safeway Inc., Sobeys Inc., Sam’s Club, Trader Joe’s, United Supermarkets, Unified Western Grocers, Wakefern Food Corp., Wal-Mart Stores, Inc., Whole Foods Market and Winco Foods LLC. |
| • | Excellence in Customer Service and Logistics. Logistics and distribution capability are key factors in ensuring fresh high quality product meets consumer demands. Management of the Company believes it has a competitive advantage through its logistics and distribution networks, which includes strategically located distribution centres. |
Investment in Joint Venture
On June 6, 2017, VFF and Emerald Health Botanicals, Inc. (“Emerald”) formed a new corporation, Pure Sunfarms Corp. (“Pure Sunfarms”). Each of VFF and Emerald owns 50% of the shares of Pure Sunfarms. VFF contributed one of its 25-acre greenhouse facilities in Delta, British Colombia as its equity contribution and Emerald agreed to contribute CA$20,000,000 to fund the conversion of the facility. Pure Sunfarms is in the process of preparing its Health Canada cannabis licence, which it expects to file on or before September 15, 2017. Once the application is accepted Pure Sunfarms will commence the conversion of the greenhouse facility to cultivate cannabis. VFF will continue to operate the facility until the end of the current tomato crop, which is expected to occur at the end of November.
As part of the formation of Pure Sunfarms, VFF incurred related transaction costs of CA$1.4 million, which have been added to the amount of the investment in accordance with IAS 28, Investments in associates and joint ventures. Included in these costs are 300,000 common share purchase warrants valued at CA$192, issued to an affiliate of a Canadian financial institution as partial consideration for services provided in respect of the formation of the joint venture. Such warrants have an exercise price of CA$2.07 per common share and expire on June 6, 2020. As at June 30, 2017, the Investment in Joint Venture of US$16.4 million is recorded in the interim statements of financial position. The final determination with respect to the transfer of assets will not be made until the end of 2017, upon removal of the tomato crop. As such, the investment and related book gain may be adjusted at year end.
4
Results of Operations
Consolidated Financial Performance
(In thousands of U.S. dollars, except per Share amounts)
| For the three months ended June 30, | For the six months ended June 30, | |||||||||||||||
| 2017 | 2016 | 2017 | 2016 | |||||||||||||
Sales | $ | 45,530 | $ | 44,441 | $ | 76,807 | $ | 76,149 | ||||||||
Cost of sales | (42,805 | ) | (41,908 | ) | (70,125 | ) | (68,558 | ) | ||||||||
Selling, general and administrative expenses | 3,853 | 3,050 | 7,077 | 6,477 | ||||||||||||
Change in biological asset (1) | (701 | ) | 66 | (1,346 | ) | (1,764 | ) | |||||||||
(Loss) from operations | (1,829 | ) | (451 | ) | (1,741 | ) | (650 | ) | ||||||||
Interest expense, net | 695 | 641 | 1.327 | 1,198 | ||||||||||||
Other income (expense) | 28 | (13 | ) | 40 | (33 | ) | ||||||||||
Gain (loss) on sale of assets | 8,572 | — | 8,564 | 12 | ||||||||||||
Provision for (Recovery of) income taxes | 1,751 | (335 | ) | 1,401 | (870 | ) | ||||||||||
Net income (loss) | 4,325 | (770 | ) | 4,135 | (1,011 | ) | ||||||||||
EBITDA (2) | 1,264 | 1,627 | 4,015 | 5,337 | ||||||||||||
Income (Loss) per share/ basic | $ | 0.11 | ($ | 0.02 | ) | $ | 0.11 | ($ | 0.03 | ) | ||||||
Income (Loss) per share/ diluted | $ | 0.11 | ($ | 0.02 | ) | $ | 0.10 | ($ | 0.03 | ) | ||||||
| (1) | Biological assets consist of the Company’s produce on the vines at the period end. Details of the changes are described in note 5 of the Company’s condensed consolidated interim financial statements for the three and six months ended June 30, 2017. |
| (2) | EBITDA is not a recognized earnings measure and does not have a standardized meaning prescribed by IFRS. Therefore, EBITDA may not be comparable to similar measures presented by other issuers. See “Non-IFRS Measures”. Management believes that EBITDA is a useful supplemental measure in evaluating the performance of the Company. |
Results of Operations for the Three Months Ended June 30, 2017 compared to the Three Months Ended June 30, 2016
Sales
Sales for the three months ended June 30, 2017 increased by $1,089, or 2%, to $45,530 from $44,441 for the three months ended June 30, 2016. The increase in sales is primarily due to an increase in supply partner revenue of 7%. The revenues from the Company’s facilities were lower as tomato pounds were lower by (2%) and cucumber pieces were lower by (2%). The increase in supply partner volume is due to an increase in the growing area of the Company’s supply partners. The Company’s tomato production decreased during the three months ended June 30, 2017 versus the same period in 2016 due to lower light levels in British Columbia that caused a decrease of (11%) in our Canadian production, which was partially covered by an increase from the Company’s Texas facilities.
The average selling price for tomatoes increased by 3% for the three months ended June 30, 2017 versus the three months ended June 30, 2016. The 2017 second quarter price increase was primarily due to an increase in the mix of the higher selling priced specialty tomato varieties. Cucumber pricing decreased by (9%) and pepper pricing increased by 1% in the second quarter of 2017 versus the comparable quarter in 2016.
Cost of Sales
Cost of sales for the three months ended June 30, 2017 increased by $897, or (2%), to $42,805 from $41,908 for the three months ended June 30, 2016. The increase is due to a 4% increase in supply partner product volume versus the same period in 2016. The cost for the Company’s facilities during the quarter was flat versus the same quarter in 2016.
5
Selling, General and Administrative Expenses
Selling, general and administrative expenses for the three months ended June 30, 2017 increased $803, or 26%, to $3,853 from $3,050 for the three months ended June 30, 2016. The increase is primarily the result of non-cash stock compensation granted in the second quarter of 2017 of $398 due to the successful launch of the cannabis initiative, as well as the reversal of a year to date bonus accrual of $300 in the second quarter of 2016 that did not occur in 2017. Excluding these two non-cash expenses, operating expenses increased by $105, or 3%, which was partially attributable to development activities involved with the new venture.
Change in Biological Asset
The net change in fair value of the biological asset for the three months ended June 30, 2017 decreased by ($767) to a loss of ($701) from $66 for the three months ended June 30, 2016. The decrease in the change in value is primarily due to a lower average selling price of the biological asset in early July 2017 versus the same period in 2016. The fair value of the biological asset as at June 30, 2017 was $6,756 as compared to $6,147 as at June 30, 2016 due to higher production in July 2017 versus July 2016.
(Loss) from Operations
Loss from operations for the three months ended June 30, 2017 was ($1,829), which was an increase of ($1,378) from a loss of ($451) for the three months ended June 30, 2016. The decrease in operating results is due to the decrease in change in fair value of the biological asset, higher cost of sales and higher non-cash operating costs in the second quarter of 2017 versus the second quarter of 2016, partially offset by increased sales.
Interest Expense, net
Interest expense, net, for the three months ended June 30, 2017 increased by $54, to $695 from $641 for the three months ended June 30, 2016. The increase is due to an increase in the interest rate on the Company’s long term debt versus the prior year.
Gain on Sale of Assets
The company recognized a gain of $8,572 on the contribution of one of its Delta greenhouse facilities in exchange for a 50% equity position in Pure Sunfarms Corp. See “Investment in Joint Venture” above.
Income Taxes (recovery)
Income tax provision (recovery) for the three months ended June 30, 2017 was $1,751 compared to income tax (recovery) of ($335) for the three months ended June 30, 2016. The income tax provision increase is due to the gain on sale of assets in 2017 as compared to the same period in 2016.
Net Income (loss)
Net Income (loss) for the three months ended June 30, 2017 improved by $5,095 to $4,325 from a loss of ($770) for the three months ended June 30, 2016 as a result of a gain on assets partially offset by the decrease in income from operations and an increase in the provision for income taxes.
EBITDA
EBITDA for the three months ended June 30, 2017 decreased by ($363), or (22%), to $1,264 from $1,627 for the three months ended June 30, 2016, principally as a result of lower production yields at the British Columbian facilities and an increase of ($105) in cash operating expenses. See the EBITDA calculation in “Non-IFRS Measures—Reconciliation of Net Income to EBITDA.”
6
Results of Operations for the Six Months Ended June 30, 2017 Compared to the Six Months Ended June 30, 2016
Net Sales
Net sales for the six months ended June 30, 2017 increased $658, or 1%, to $76,807 compared to $76,149 for the six months ended June 30, 2016. The increase in net sales is due an increase in supply partner revenues of 9% over the comparable period in 2016. Company product revenues decreased (5%) for the six months ended June 30, 2017 versus the six months ended June 30, 2016 due to lower tomato pounds at the British Columbia facilities and a (1%) decrease in the average selling price.
The net price for all tomato pounds sold was flat for the six months ended June 30, 2017 versus the six months ended June 30, 2016. Pepper prices decreased (9%) and pounds increased 15% over the comparable period in 2016 and cucumber prices decreased (9%) and pieces increased 3% for the six months ended June 30, 2017 over the comparable period in 2016.
Cost of Sales
Cost of sales for the six months ended June 30, 2017 increased ($1,567), or (2%), to $70,125 from $68,558 for the six months ended June 30, 2016. The increase is due to the increase in supply partner cost of sales of 9%. The cost at the Company’s facilities decreased by (5%) due to lower costs per pound in 2017 versus the same period in 2016.
Change in fair value of biological asset, net
The net change in fair value of biological asset for the six months ended June 30, 2017 increased $418 to ($1,346) from ($1,764) for the six months ended June 30, 2016. The increase is due to a lower beginning value on January 1, 2017 versus the January 1, 2016.
Selling, General and Administrative Expenses
Selling, general and administrative expenses for the six month period ended June 30, 2017 increased ($600), or (9%), to $7,077 from $6,477 for the six month period ended June 30, 2016. The increase is due to increases in sales and marketing costs associated with the increase in supply partner revenues, increasing retailer market share and higher non-cash stock compensation expense of $398 in 2017.
(Loss) from Operations
(Loss) from operations for the six months ended June 30, 2017 is ($1,741), which was an increase (loss) of ($1,091) from a loss of ($650) for the six months ended June 30, 2016. The decrease in operating results is due to an increase in cost of sales and selling, general and administrative expenses partially offset by an increase in sale and an increase in the change in biological asset.
Interest Expense, net
Interest expense, net, for the six month period ended June 30, 2017 increased ($129) to $1,327 from $1,198 for the six month period ended June 30, 2016. The increase is due to an increase in the Company’s long term debt borrowing rate effective on May 1, 2016.
Income Taxes (recovery)
Income tax provision (recovery) for the six month period ended June 30, 2017 was $1,401 compared to a recovery of ($870) for the six month period ended June 30, 2016. The income tax provision increase is due to the gain on sale of assets in 2017 as compared to the same period in 2016.
7
Gain on Sale of Assets
The company recognized a gain of $8,564 on the contribution of the one of the Company’s Delta greenhouse facilities and land to Pure Sunfarms Corp. in exchange for a 50% equity stake in the corporation. See “Investment in Joint Venture” above.
Net Income (Loss)
Net Income (loss) for the six month period ended June 30, 2017 increased $5,146 to $4,135 from a loss of ($1,011) for the six month period ended June 30, 2016. The increase is a result of a gain on assets partially offset by the decreased in income from operations, and an increase in the provision for income taxes.
EBITDA
EBITDA for the six month period ended June 30, 2017 decreased by ($1,322) to $4,015 from $5,337 for the six month period ended June 30, 2016, primarily as a result of higher cost of sales and selling, general and administrative expenses partially offset by an increase in revenues. See the EBITDA calculation in “Non-IFRS Measures – Reconciliation of Net Earnings to EBITDA.”
Selected Statement of Financial Position Data
| As at June 30, 2017 | As at December 31, 2016 | |||||||
Total assets | $ | 146,799 | $ | 134,965 | ||||
Total liabilities | $ | 76,372 | $ | 67,578 | ||||
Shareholders’ equity | $ | 70,427 | $ | 67,387 | ||||
Non-IFRS Measures
References in this MD&A to “EBITDA” are to earnings before interest, taxes, depreciation, amortization, foreign currency exchange gains and losses on translation of long-term debt, unrealized gains on the changes in the value of derivative instruments, unrealized change in biological asset, stock compensation, and gains and losses on asset sales. EBITDA is a cash flow measure that is not recognized under IFRS and does not have a standardized meaning prescribed by IFRS. Therefore, EBITDA may not be comparable to similar measures presented by other issuers. Investors are cautioned that EBITDA should not be construed as an alternative to net income or loss determined in accordance with IFRS as an indicator of the Company’s performance or to cash flows from operating, investing and financing activities as measures of liquidity and cash flows. Management believes that EBITDA is an important measure in evaluating the historical performance of the Company.
8
Reconciliation of Net Income to EBITDA
The following table reflects a reconciliation of net income to EBITDA, as presented by the Company:
| (in thousands of U.S. dollars) | For the three months ended June 30, | For the six months ended June 30, | ||||||||||||||
| 2017 | 2016 | 2017 | 2016 | |||||||||||||
Net income (loss) | $ | 4,325 | ($ | 770 | ) | $ | 4,135 | ($ | 1,011 | ) | ||||||
Add: | ||||||||||||||||
Amortization | 1,949 | 2,084 | 3,900 | 4,147 | ||||||||||||
Foreign currency exchange loss (gain) | (13 | ) | 22 | 1 | 3 | |||||||||||
Interest expense | 695 | 641 | 1,327 | 1,198 | ||||||||||||
Income taxes (recovery) | 1,751 | (335 | ) | 1,401 | (870 | ) | ||||||||||
Stock based compensation | 428 | 51 | 469 | 94 | ||||||||||||
Change in biological asset | 701 | (66 | ) | 1,346 | 1,764 | |||||||||||
(Gain) Loss on disposal of assets | (8,572 | ) | — | (8,564 | ) | 12 | ||||||||||
|
|
|
|
|
|
|
| |||||||||
EBITDA | $ | 1,264 | $ | 1,627 | 4,015 | $ | 5,337 | |||||||||
Liquidity
Cash flows
The Company expects to provide adequate financing to maintain and improve its property, plant and equipment and to fund working capital needs for the foreseeable future from cash flows from operations, and, if needed, from additional borrowings under the Credit Facilities (as defined below) or other long-term facilities, including capital leases or subordinated debt issuances.
For the three months ended June 30, 2017, cash flows from operating activities before changes in non-cash working capital and change in biological asset totalled $569 (2016 – $1,441) and for the six months ended June 30, 2017 was $2,657 (2016 – $3,314).
Capital expenditures totalled $562 for the three months ended June 30, 2017 (2016 – $746) and $993 for the six months ended June 30, 2017 (2016 – $1,392).
The cash (used in) provided by financing activities for the three months ended June 30, 2017 totalled ($471) (2016 – ($1,496)) and for the six months ended June 30, 2017 totalled $3,068 (2016 – ($152)). For the three months ended June 30, 2017, the cash provided by financing activities primarily consisted of operating loan borrowings of $1,000 offset by net term debt payments of ($818) and interest payments of ($670) (2016 – operating loan borrowings $1,000, debt payments of ($2,006) and interest paid ($508)). For the six months ended June 30, 2017, the cash provided by financing activities primarily consisted of operating loan borrowings of $6,000 offset by net term debt payments of ($1,656) and interest payments of ($1,280) (2016 – operating loan borrowings $4,000, debt payments of ($3,104) and interest paid ($1,059)).
Capital Resources
| (in thousands of U.S. dollars unless otherwise noted) | Maximum | Outstanding June 30, 2017 | ||||||
Operating Loan | CA$ | 13,000 | $ | 6,000 | ||||
Term Loan | $ | 42,211 | $ | 42,211 | ||||
VFCE Loan | CA$ | 2,244 | CA$ | 2,244 | ||||
The Company is party to a Term Loan financing agreement with a Canadian creditor (“FCC Loan”). This non-revolving variable rate term loan was amended in March 2016 and now has a maturity date of May 1, 2021 and a balance of $42,211 as at June 30, 2017. The outstanding balance is repayable by way of monthly installments of principal and interest based on an amortization period of 15 years, with the balance and any
9
accrued interest to be paid in full on maturity. Monthly principal payments are $253 effective June 1, 2016. As at June 30, 2017, borrowings under the FCC Loan are subject to an interest rate of 5.67% per annum (June 30, 2016 – 5.14% per annum). The Company’s interest rate on the FCC Loan is determined based on the Company’s Debt to EBITDA ratio on December 31 of the prior year and the current monthly applicable LIBOR rate.
The Company is also party to a variable rate line of credit agreement with a Canadian chartered bank that has a maturity date of May 31, 2021 (the “Operating Loan” and together with the FCC Loan, the “Credit Facilities”). The Operating Loan is subject to margin requirements stipulated by the bank. As at June 30, 2017, $6,000 was drawn on the Operating Loan (December 31, 2016 – $nil), which is available to a maximum of CA$13,000, less outstanding letters of credit of US$320 and CA$38 (or US$29).
The Company’s subsidiary, VFCE, has a non-revolving fixed rate loan with a maturity date of June 30, 2023, a fixed interest rate of 4.98% per annum, and monthly payments of principal and interest of CA$36. As at June 30, 2017, the outstanding balance was CA$2,244 (US$1,728) (December 31, 2016 – US$1,806).
As security for the FCC Loan, the Company has provided promissory notes, a first mortgage on the VFF-owned greenhouse properties, and general security agreements over its assets. In addition, the Company has provided full recourse guarantees and has granted security therein. The carrying value of the assets and securities pledged as collateral as at June 30, 2017 was $126,282 (December 31, 2016 – $130,700).
As security for the Operating Loan, the Company has provided promissory notes and a first priority security interest over its accounts receivable and inventory. In addition, the Company has granted full recourse guarantees and security therefore. The carrying value of the assets pledged as collateral as at June 30, 2017 was $36,562 (December 31, 2016 – $30,515).
The borrowings are subject to certain positive and negative covenants, which include debt coverage ratios. As at June 30, 2017, the Company was in compliance with all of its covenants.
Accrued interest payable on the Credit Facilities as at June 30, 2017 was $204 (December 31, 2016 – $202) and these amounts are included in accrued liabilities in the interim statements of financial position.
Transaction costs incurred in connection with these financing activities are deferred and amortized over the terms of the related financing agreement. Total deferred financing costs, net of accumulated amortization, are netted against long-term debt on the interim statements of financial position, and total $280 as at June 30, 2017 (December 31, 2016 – $314).
Contractual Obligations and Commitments
Information regarding the Company’s contractual obligations at June 30, 2017 is set forth in the table below:
| (in thousands of U.S. dollars) | Total | 1 year | 2-3 years | 4-5 years | More than 5 years | |||||||||||||||
Long-term debt | $ | 43,939 | $ | 3,287 | $ | 6,614 | $ | 33,714 | $ | 324 | ||||||||||
Operating leases | 4,029 | 1,271 | 1,809 | 929 | 20 | |||||||||||||||
Capital leases | 181 | 38 | 143 | — | — | |||||||||||||||
|
|
|
|
|
|
|
|
|
| |||||||||||
Total | $ | 48,149 | $ | 4,596 | $ | 8,566 | $ | 34,643 | $ | 344 | ||||||||||
|
|
|
|
|
|
|
|
|
| |||||||||||
Capital Expenditures
During the three and six months ended June 30, 2017, the Company purchased approximately $562 and $993, respectively, of capital assets. Capital expenditures incurred for 2017 were used for replacements or improvements to existing facilities, distribution centres or information technology systems or hardware.
10
Management continues to review new capital expenditures to support its strategic plan of achieving cost efficiencies through increased productivity. Management may elect, where appropriate, to sell inefficient or non-strategic assets to produce cash to wholly or partially finance new capital expenditures. The Company will also borrow to maintain, improve and replace capital assets when the return on such investments exceeds targeted thresholds for internal rates of return. There can be no assurance, however, that sources of financing will be available, or will be available on terms favourable to the Company, or that these strategic initiatives will achieve adequate cost reduction in actual implementation or in light of the competitive pressures on the cost of raw materials and other factors of production. Management believes that its recurring capital expenditures will be funded and supported from its ongoing operations.
During the three and six months ended June 30, 2017, the Company incurred $638 and $1,289, respectively, in costs to maintain its capital assets. These expenses are classified as repair and maintenance and are included in cost of sales. Management forecasts approximately $2,500 of annual costs to maintain the Company’s capital assets.
Summary of Quarterly Results
For the three months ended:
(in thousands of U.S. Dollars, except per share amounts) | Jun 30, 2017 | Mar 31, 2017 | Dec 31, 2016 | Sept 30, 2016 | Jun 30, 2016 | Mar 31, 2016 | Dec 31, 2015 | Sept 30, 2015 | ||||||||||||||||||||||||
Sales | 45,530 | 31,277 | $ | 37,308 | $ | 42,045 | $ | 44,441 | $ | 31,708 | $ | 35,121 | $ | 37,855 | ||||||||||||||||||
Net income (loss) | $ | 4,325 | ($ | 190 | ) | $ | 453 | ($ | 1,425 | ) | ($ | 770 | ) | ($ | 241 | ) | $ | 2,486 | ($ | 318 | ) | |||||||||||
Basic earnings (loss) per share | $ | 0.11 | ($ | 0.00 | ) | $ | 0.01 | ($ | 0.04 | ) | ($ | 0.02 | ) | ($ | 0.01 | ) | $ | 0.06 | ($ | 0.01 | ) | |||||||||||
Diluted earnings (loss) per share | $ | 0.11 | ($ | 0.00 | ) | $ | 0.01 | ($ | 0.04 | ) | ($ | 0.02 | ) | ($ | 0.01 | ) | $ | 0.06 | ($ | 0.01 | ) | |||||||||||
The Company’s Canadian operations peak production period is in the summer months, with no production during the winter season. As a result, prices for products from the Company’s Canadian operations have historically followed a seasonal trend of higher prices at the start and end of its crop year, with lower prices in the summer months when the supply of product is greatest. Conversely, the Company’s U.S. operations winter production allows it to realize higher prices during the October through March period, due to the reduced supply of greenhouse produce in North America during the winter months. The complementary nature of the growing seasons of the Company’s Canadian and U.S. operations allows the Company to maintain and service its core retail accounts year round.
Financial Instruments and Risk Management
Risk Management
The Company is exposed to the following risks as a result of holding financial instruments: market risk, credit risk, interest rate risk, foreign exchange risk and liquidity risk. The following is a description of these risks and how they are managed by the Company.
Market Risk
Market risk is the risk that the fair value or future cash flows of a financial instrument will fluctuate because of changes in the market place.
Credit Risk
Credit risk is the risk that the Company will incur a loss due to the failure by its customers or other parties to meet their contractual obligations. Financial instruments that potentially subject the Company to significant concentrations of credit risk consist primarily of cash and cash equivalents and trade receivables.
The Company limits its exposure to credit risk by placing its cash and cash equivalents with high credit quality financial institutions.
11
The Company’s trade receivables had one customer that represented more than 10% of the balance of trade receivables, representing 10.0% of the balance of trade receivables as at June 30, 2017 (2016 – two customers, 13.2% and 10.1%). The Company believes that its trade receivables risk is limited due to the high credit quality of its customers and the protection afforded to the Company by the Perishable Agricultural Commodities Act (the “PACA”) for its sales in the United States, which represent approximately 85% of the Company’s annual sales. The PACA protection gives a claim filed under the PACA first lien on all PACA assets (which include cash and trade receivables). The PACA fosters trading practices in the marketing of fresh and frozen fruits and vegetables in interstate and foreign commerce. It prohibits unfair and fraudulent practices and provides a means of enforcing contracts. Historical write-offs have represented less than one-half of one percent of sales.
Trade receivables for each customer were evaluated for collectability and an allowance for doubtful accounts has been estimated. At June 30, 2017, the allowance for doubtful accounts balance was $50 (2016 – $50). The Company has not recorded bad debt expense during the three and six months ended June 30, 2017 (2016 – $nil).
At June 30, 2017, 92.5% (Dec. 2016 – 87.4%) of trade receivables were outstanding less than 30 days, 6.6% (Dec. 2016 – 9.5%) were outstanding for between 30 and 90 days and the remaining 0.9% (Dec. 2016 – 3.1%) were outstanding for more than 90 days. Trade receivables are considered past due based on the contract terms agreed to with a customer. Aged receivables that are past due are not considered impaired unless customer specific information indicates otherwise.
Interest Rate Risk
Interest rate risk is the risk that the fair value or future cash flows of a financial instrument will fluctuate because of changes in market interest rates.
The Company has used derivative instruments to reduce market exposure to changes in interest rates. The Company has used derivative instruments only for risk management purposes and not for generating trading profits.
Liquidity Risk
Liquidity risk is the risk that the Company will not be able to meet its obligations as they become due. The following are the contractual maturities of financial liabilities as at June 30, 2017:
(in thousands of U.S. dollars) Financial liabilities | Contractual cash flows | 0 to 12 months | 12 to 24 months | After 24 months | ||||||||||||
Accounts payable and accrued liabilities | $ | 19,338 | $ | 19,338 | $ | — | $ | — | ||||||||
Bank debt | 43,939 | 3,287 | 3,301 | 37,351 | ||||||||||||
|
|
|
|
|
|
|
| |||||||||
| $ | 63,277 | $ | 22,625 | $ | 3,301 | $ | 37,351 | |||||||||
|
|
|
|
|
|
|
| |||||||||
It is the Company’s intention to meet these obligations through the collection of current accounts receivable and cash. The Company has available lines of credit of up to CA$13,000 (as at June 30, 2017, $6,000 was outstanding and US$320 and CA$38 was utilized in the form of outstanding letters of credit). If the current resources and cash generated from operations are insufficient to satisfy its obligations, the Company may seek to issue additional equity or to arrange debt or other financing.
Under the terms of the Credit Facilities, the Company is subject to a number of covenants, including debt service covenants. These covenants could reduce the Company’s flexibility in conducting the Company’s operations by limiting the Company’s ability to borrow money and may create a risk of default on the Company’s debt (including by a cross-default to other credit agreements) if the Company cannot satisfy or continue to satisfy these covenants. In the event that the Company cannot comply with a debt covenant, or anticipates that it will be unable to comply with a debt covenant in the future, management may seek a waiver and/or amendment from the applicable lenders in respect of any such covenant in order to avoid any breach
12
or default that might otherwise result there from. If the Company defaults under any of the Credit Facilities and the default is not waived by the applicable lenders, the debt extended pursuant to all of its debt instruments could become due and payable prior to its stated due date. The Company cannot give any assurance that (i) its lenders will continue to agree to any covenant amendments or waive any covenant breaches or defaults that may occur under the applicable debt instruments, and (ii) it could pay this debt if it became due prior to its stated due date. Accordingly, any default by the Company under its existing debt that is not waived by the applicable lenders could materially adversely impact the Company’s results of operations and financial results and may have a material adverse effect on the trading price of its common shares. See also “Risk Factors – Dependence Upon Credit Facilities” in the Company’s current Annual Information Form.
Environmental, Health and Safety Risk
The Company’s operations are subject to national, regional and local environmental, health and safety laws and regulations governing, among other things, discharge to air, land and water, the handling and storage of fresh produce, waste disposal, the protection of employee health, safety and the environment. The Company’s greenhouse facilities could experience incidents, malfunctions or other unplanned events that could result in discharges in excess of permitted levels resulting in personal injury, fines, penalties or other sanctions and property damage. The Company must maintain a number of environmental and other permits from various governmental authorities in order to operate. Failure to maintain compliance with these requirements could result in operational interruptions, fines or penalties, or the need to install potentially costly pollution control technology. Compliance with current and future environmental laws and regulations, which are likely to become more stringent over time, including those governing greenhouse gas emissions, may impose additional capital costs and financial expenditures, which could adversely affect the Company’s operational results and profitability.
The Company is committed to protecting the health and safety of employees and the general public, and to sound environmental stewardship. The Company believes that prevention of incidents and injuries, and protection of the environment, benefits everyone and delivers increased value to its shareholders, customers and employees. The Company has health and safety and environmental management and systems and has established policies, programs and practices for conducting safe and environmentally sound operations. Regular reviews and audits are conducted to assess compliance with legislation and Company policy.
Outlook
Overview
The forward-looking statements contained in this section and elsewhere in this MD&A are not historical facts, but rather, reflect the Company’s current expectations regarding future results or events and are based on information currently available to Management. Certain material factors and assumptions were applied in providing these forward-looking statements. See the “Forward-Looking Statements” section of this MD&A.
In addition to the Company’s continual focus on increasing its revenues and profits on its core crops – tomatoes, cucumbers and peppers – the Company is actively exploring whether to produce certain higher margin alternative crops. In conjunction with its traditional produce business, the Company entered into a new distribution agreement with a new Mexican high-end greenhouse grower in Yecapixtla, Morleos, Mexico, who will be in production with approximately 45 acres in the winter of 2017 and is planning an additional 43 acres of capacity by the end of 2018. The lower cost Mexican produce has the potential to substantially increase the Company’s distribution business allowing the Company to increase its market share with certain retail accounts.
On June 6, 2017 the Company announced an initiative into growing cannabis through a joint venture with an existing licensed producer – Emerald Heath Therapeutics, Inc., which the Company would contribute one of its Delta greenhouses and growing knowledge in exchange for a 50% equity position. Emerald is contributing
13
CA$20m for its 50% equity interest. The joint venture is named Pure Sunfarms Corp. The new venture is in the process of preparing its license application to become a licensed producer of cannabis under the Access to Cannabis for Medical Purposes Regulations. Management believes that if it the new venture it successful in obtaining a license, once the entire facility is retrofitted and fully licensed it will the largest commercial cannabis production facility in Canada. Management believes it will produce cannabis for CA$1 per gram with margins of at least 50%. As such, the Company’s 50% equity interest is capable of generating over 10 times the revenue and profits of current expected revenues and profits from the tomato crop currently grown in the facility. There can be no assurance, however, that the new venture will ultimately obtain a license to produce cannabis.
The Company continues to look at alternative crops for its Texas facilities and has had discussions with third parties about berries and other non-traditional hydroponic greenhouse produce. Management is committed to only conducting activities and growing operations which are federally legal, as such it will not grow, nor invest in any cannabis related business in the U.S. until it is federally legal.
Growth expenditures
The Company expects to spend between $2.0 to $2.5 million on capital expenditures in 2017. These expenditures are to repair and enhance existing growing and packhouse systems either due to obsolesces of the system or to improve operational efficiencies.
Disclosure Controls and Procedures
Disclosure controls and procedures have been designed to ensure that information to be disclosed by the Company is accumulated and communicated to management, as appropriate, to allow timely decisions regarding required disclosures. The Chief Executive Officer and Chief Financial Officer have concluded, as of the end of the period covered by the interim and year end filings, that the Company’s disclosure controls and procedures are appropriately designed and operating effectively to provide reasonable assurance that material information relating to the issuer is made known to them by others within the Corporation.
Internal Control over Financial Reporting
Internal control over financial reporting is a process designed to provide reasonable assurance that all assets are safeguarded, transactions are appropriately authorized and to facilitate the preparation of relevant, reliable and timely information. A control system, no matter how well conceived or operated, can provide only reasonable, not absolute, assurance that the objective of the control system is met. Management has assessed the effectiveness of the Company’s internal control over financial reporting as defined by National Instrument 52-109, Certification of Disclosure in Issuers’ Annual and Interim Filings. Management has concluded that their internal control over financial reporting was effective as of June 30, 2017. There were no material changes in the Company’s internal control over financial reporting that occurred during the three months ended June 30, 2017 that had materially affected, or is reasonably likely to affect the Company’s internal controls over financial reporting.
Risks and Uncertainties
The Company is subject to various risks and uncertainties which are summarized below, as well as those discussed in this MD&A. Additional details are contained in the Company’s current Annual Information Form dated March 31, 2017 filed on SEDAR, which can be accessed electronically at www.sedar.com.
Risks Relating to the Company
| • | Product Pricing |
| • | Maintain Profitability |
| • | Pure Sunfarms Corp. obtaining a license to cultivate cannabis |
| • | Risks Inherent in the Agricultural Business |
| • | Natural Catastrophes |
14
| • | Retail Consolidation |
| • | Covenant Risk |
| • | Dependence Upon Credit Facilities |
| • | Competition |
| • | Transportation Disruptions |
| • | Labour Availability |
| • | Governmental Regulations |
| • | Product Liability |
| • | Key Executives |
| • | Uninsured and Underinsured Losses |
| • | Cyber Security |
| • | Vulnerability to Rising Energy Cost |
| • | Risks of Regulatory Change |
| • | Environmental, Health and Safety Risk |
| • | Foreign Exchange Exposure |
| • | Risks Associated with Cross Border Trade |
| • | Technological Advances |
| • | Accounting Estimates |
| • | Growth |
Risks Related to Tax
| • | Potential U.S. Permanent Establishment of VF Canada GP, VFCLP and VFF |
| • | Advances by VF Operations Canada Inc. to U.S. Holdings |
| • | Transfer Pricing |
| • | U.S. Real Property Holding Corporation |
Off-Balance Sheet Arrangements
The Company does not have any off-balance sheet arrangements.
Critical Accounting Estimates
Accounts Receivable
Accounts receivable are measured at amortized cost and due within contractual payment terms and are stated at amounts due from customers net of an allowance for doubtful accounts. Credit is extended based on an evaluation of a customer’s financial condition. Accounts outstanding longer than the contractual payment terms are considered past due. The Company determines its allowance by considering a number of factors, including the length of time trade accounts receivable are past due, the Company’s previous loss history and the customer’s current ability to pay its obligation to the Company. The Company writes off accounts receivable when they become uncollectible, and payments subsequently received on such receivables are credited to the bad debt expense.
Inventories
Inventories of Company-grown produce consist of raw materials, labour and overhead costs incurred less costs charged to cost of sales throughout the various crop cycles, which end at various times throughout the year and exclude biological assets (see below). Cost of sales is based upon incurred and estimated costs to be incurred from each crop allocated to both actual and estimated future yields over each crop cycle. The cost of produce inventory purchased from third parties is valued at the lower of cost or net realizable value.
Biological Assets
Biological assets consist of the Company’s produce on the vines at the period end. The produce on the vine is measured at fair value less costs to sell and complete, with any change therein recognized in profit or loss. Costs to sell include all costs that would be necessary to sell and complete the assets, including finishing and transportation costs.
15
Income Taxes
The Company utilizes the assets and liability method of accounting for income taxes under which future income tax assets and liabilities are recognized for the estimated future income tax consequences attributable to differences between the financial statement carrying value amount and the tax basis of assets and liabilities. Management uses judgment and estimates in determining the appropriate rates and amounts in recording future taxes, giving consideration to timing and probability. Actual taxes could significantly vary from these estimates as a result of future events, including changes in income tax law or the outcome of reviews by tax authorities and related appeals. The resolution of these uncertainties and the associated final taxes may result in adjustment to the Company’s tax assets and tax liabilities.
Future income tax assets are recognized to the extent that realization is considered more likely than not. The Company considers past results, current trends and outlooks for future years in assessing realization of income tax assets.
Impairment of Financial and Non-Financial Assets
At the end of each reporting period, the Company reviews the carrying amounts of its long lived assets to determine whether there is any indication that those assets have suffered an impairment loss. If any such indication exists, the recoverable amount of the asset is estimated in order to determine the extent of the impairment loss, if any. The Company estimates the recoverable amounts of the cash-generating unit (“CGU”) to which the asset belongs.
Where a reasonable and consistent basis of allocation can be identified, corporate assets are also allocated to individual CGU’s, or otherwise they are allocated to the smallest group of CGU’s for which a reasonable and consistent allocation basis can be identified. Identifiable cash flows are largely independent of the cash flows of other assets and liabilities. This was determined to be the Canadian and U.S. operations.
Recoverable amount is the higher of the fair value less costs to sell and the value in use. In assessing value in use, the estimated future cash flows are discounted to their present value using a pre-tax discount rate that reflects current market assessments of the time value of money and the risks specific to the asset for which the estimates of future cash flows have not been adjusted. If the recoverable amount of an asset or CGU is estimated to be less than its carrying amount, the carrying amount of the asset or CGU is reduced to its recoverable amount. An impairment loss is recognized immediately in the statement of income.
Where an impairment loss subsequently reverses for assets with a finite useful life, the carrying amount of the asset or CGU is increased to the revised estimate of its recoverable amount, but so that the increased carrying amount does not exceed the carrying amount that would have been determined had no impairment loss been recognized for the asset or CGU in prior periods. A reversal of an impairment loss is recognized immediately in the statement of income.
Due to the above-noted considerations, which are based on the Company’s best available information, the Company has not recorded any impairment charge on its non-financial assets in the six months ended June 30, 2017.
Property, Plant and Equipment – Useful Lives
Management estimates the useful lives of property, plant and equipment based on the period during which the assets are expected to be available for use. The amounts and timing of recorded expenses for depreciation of property, plant and equipment for any period are affected by these estimated useful lives. The estimates are reviewed at least annually and are updated if expectations change as a result of physical wear and tear, technical or commercial obsolescence and legal or other limits to use. It is possible that changes in these factors may cause significant changes in the estimated useful lives of the Company’s property, plant and equipment in the future.
16
Land Revaluation
Management concluded that given significant changes in the fair market value of the Company’s land assets, the revaluation method of accounting for land used in production is a more appropriate accounting policy than historical cost. IAS 8, Accounting Policies, Changes in Accounting Estimates and Errors, allows for prospective application of this policy change and therefore the policy change has been applied to year ended December 31, 2016.
Accounting Standards Issued and Not Applied
The IASB periodically issues new standards and amendments or interpretations to existing standards. The new pronouncements listed below are those policy changes that management considers relevant to the Company now or in the future. This is not intended to be a complete list of new pronouncements made during the year.
IFRS 9, Financial Instruments, addresses classification and measurement of financial assets and financial liabilities, and replaces the multiple category and measurement models in IAS 39, Financial Instruments-Recognition and Measurement. The required adoption date for IFRS 9 has been extended to annual periods beginning on or after January 1, 2018, with early adoption permitted. IFRS 9 is not expected to have a material impact on amounts recorded in the interim financial statements of the Company.
IFRS 15, Revenue from Contracts with Customers, replaces IAS 18, Revenue, and IAS 11, Construction Contracts, and the related Interpretations on revenue recognition. IFRS 15, issued in May 2014, establishes the requirements for recognizing revenue that apply to all contracts with customers, except for contracts that are within the scope of the Standards on leases, insurance contracts, and financial instruments. IFRS 15 is effective for annual periods beginning on or after January 1, 2018, with early adoption permitted. Management is currently evaluating the impact of IFRS 15.
IFRS 16, Leases, issued in January 2016, replaces IAS 17, Leases, and related Interpretations. IFRS 16 establishes the principles for the recognition, measurement, presentation and disclosure of leases for both parties to a contract, ie the customer (lessee) and the supplier (lessor). IFRS 16 is effective for annual periods beginning on or after January 1, 2019, with early adoption permitted only if the company also applies IFRS 15. Management is currently assessing the impact on the Company’s consolidated interim financial statements along with the timing of adoption of IFRS 16. Management expects that IFRS 16 will result in the following: a) an increase in assets and liabilities as fewer leases will be expensed as payments are made; b) an increase in depreciation expenses; and c) an increase in cash flow from operating activities as these lease payments will be recorded as financing outflows in the cash flow statements.
Further details of new accounting standards and potential impact on the Company can be found in the Company’s condensed consolidated interim financial statements for the three and six months ended June 30, 2017.
Related Party Transactions
As at June 30, 2017, included in other assets is a $95 promissory note from an employee of the Company in connection with a relocation agreement. The Company has no other commitments as a result of related party transactions during the year.
Outstanding Share Data
The beneficial interests in the Company are currently divided into interests of three classes, described and designated as “Common Shares”, “Special Shares” and “Preferred Shares”, respectively. An unlimited number of Common Shares, Special Shares and Preferred Shares are issuable pursuant to VFF’s constating documents.
17
As of the date hereof, VFF has outstanding: (i) 39,166,279 Common Shares carrying the right to one vote at a meeting of voting shareholders of VFF; (ii) nil (0) Special Shares; and (iii) nil (0) Preferred Shares. In conjunction with the formation of Pure Sunfarms Corp., the Company issued 300,000 common share purchase warrants to an affiliate of a Canadian financial institution as partial consideration for services provided in respect thereof. Such warrants have an exercise price of CA$2.07 per common share and expire on June 6, 2020.
For further details on the structure of the Company or the rights attached to each of the above-mentioned securities, please refer to the Company’s current Annual Information Form dated March 31, 2017 which is available electronically at www.sedar.com.
Forward-Looking Statements
This MD&A contains certain “forward-looking statements”. These statements, including those set out under “Outlook”, relate to future events or future performance and reflect the Company’s expectations regarding its growth, results of operations, performance, business prospects, opportunities, industry performance and trends, and capital availability, including the Company’s expectations for 2017 and 2018 performance. These forward-looking statements reflect the Company’s current internal projections, expectations or beliefs and are based on information currently available to the Company. In some cases, forward-looking statements can be identified by terminology such as “may”, “will”, “should”, “expect”, “plan”, “anticipate”, “believe”, “estimate”, “predict”, “potential”, “continue” or the negative of these terms or other comparable terminology. A number of factors could cause actual events or results to differ materially from the results discussed in the forward-looking statements, including product pricing trends and the Company’s continued compliance with the terms of its Credit Facilities. In evaluating these statements, you should specifically consider various factors, including, but not limited to, such risks and uncertainties as availability of resource, competitive pressures and changes in market activity, risks associated with U.S. and international sales and foreign exchange, regulatory requirements and all of the other matters discussed under “Risk Factors” and elsewhere in this MD&A. Actual results may differ materially from any forward-looking statement. Although the Company believes that the forward-looking statements contained in this MD&A are based upon reasonable assumptions, you cannot be assured that actual results will be consistent with these forward-looking statements. These forward-looking statements are made as of the date of this MD&A, and other than as specifically required by applicable law, the Company assumes no obligation to update or revise them to reflect new events or circumstances.
Public Securities Filings
You may access other information about the Company, including its current Annual Information Form and other disclosure documents, reports, statements or other information that it files with the Canadian securities regulatory authorities, through SEDAR at www.sedar.com.
18